A non-re sorbable yet absorbent PAPC composition having a cellular structure with porous and non porous surface.
Robert Joyce will present at (3) conferences during the fall of 2024. The SPE FOAMS 2024 conference in King of Prussia September 17-20 / Advanced Manufacturing Minneapolis 2024 - October 16-17 and AMI Performance Polyamides in Cleveland November. He will share his 20+ years of growing innovative foaming technology to eventually 3D print PAPC+Nylon66 having bone like performance.
Military Medicine publication of 3D printing FibreTuff PAPC in austere deployment and point-of-care rapid fabrication. A variety of 3D printed examples include medical supplies, including human tissues and bioactive bandages, in prolonged field care scenarios. In this pilot project, the aim was to investigate the ability to 3D print a range of potential biomedical supplies and solutions in an austere field environment. FibreTuff is thankful for being selected as the biocompatible filament of choice.
FibreTuff is listed in the Top 10 3D Printing Trends in 2023 by StartUs insights for Biocompatible Materials. We're very Thankful for the recognition. Many don't realize printed FibreTuff PAPC has micropores. It has been tested in vivo and by University's in vitro without any adverse effects to cells and tissues. Matter of fact, Bioactivity was present and there has been osteoblast adhesion without hydroxyapatite (Ha). We have a huge upside because FibreTuff PAPC has non resorbable ingredients without pore closure.
The 3D Printing of FibreTuff PAPC is the best material to replace bone like properties. One can construct cortical and cancellous bone, plus, there is a nonbinary radiographic image not radiolucent or radiopaque. The radiopacity isn't too bright for showing bone bridging and we believe won't require implant removal to identify evidence based healing. Further, we believe this radiopacity will be very beneficial to ascertain data for Artificial Intelligence - process optimization for quality of micropore construction.
The 3D Printing of FibreTuff PAPC+Nylon66 has been implanted for a Dental Bone Grafting Material. This printed PAPC biomaterial was autoclaved at 250C for 20min at 28psi, immersed in antibiotics, then customized to the desired shape, implanted and closed with sutures.
Christophe Marquette benchmarking the 3D printing of FibreTuff PAPC material for bioreactor development. The CAD design was produced by the 3d.FAB platform team. The design was performed by Lucas Lemarié, PhD student at SEGULA Technologies , a great example of thread integration.
Dr Sikder of Cleveland State University performed a Bioactivity investigation of 3D printing FibreTuff, having microporous cellular structure. Dr Sikder immersed the microporous disc made with FibreTuff in Simulated Body Fluids (SBF). The SEM showed printed FibreTuff was biocompatible and had apatite formation.
The 3D printing of FibreTuff has been investigated for bioactivity. The results showed biocompatible behavior with unprecedented apatite formation. These results with FibreTuff displayed improved results versus HaPEEK or AMPPEEK. FibreTuff PAPC has passed USP Class VI testing performed by NAMSA for temporary implant status.
The 3D Printing of porous scaffolds made with FibreTuff PAPC were investigated in vitro and showed osteoblast adhesion. These bone tissue engineering tests were preformed by Dr Safadi at the Medical college in Northeast Ohio.
The printed FibreTuff PAPC anatomical bone models like this vertebrae are printed with filaments even powders. After 3D printing the bone models, they can be sterilized by standard methods such as Autoclave. The printed FibreTuff PAPC+Nylon66 has hydrophilicity helping attract antibiotic liquids to minimize infection. This printed PAPC features surpasses several Chinese scientist’s whom have identified a nano mineralized Hydroxyapatite Nylon66 (HaNylon66) replacement of titanium, more specifically, PEEK for spinal implants. Reference: Zhipeng Deng, Bowen Hu, Xi Yang, Lei Wang, and Yueming Song The improved bioactive n- HA/PA66 cage versus the PEEK cage in anterior cervical fusion: results from a 6-year follow- up and a case-matched study.
The FibreTuff PAPC - Polyamide, Polyolefin and Cellulose is an advanced biomaterial with radiopacity. This 3D printing FibreTuff PAPC micropore cellular structure has a radiographic image - CT Scans, Xray and Ultrasound. Further, the printed FibreTuff PAPC image can be -200HU to 200HU, less or equal to the attenuation of real bone. The advantage is identifying bone bridging or the healing process.Not radiopaque or radiolucent.
The 3D printing FibreTuff PAPC is the best material to replace bone like behavior. The printed PAPC once exposed to fluids becomes more flexible with improved impact.
A Dr Hartman, cranio maxillofacial surgeon at Hartman Oral and Maxillofacial Surgery, P.C. has printed FibreTuff medical grade filament and produced anatomical bone like models for CT scans.His work confirms 3D printing FibreTuff meets the standards set by the Radiological Society of North America (RSNA) per the November 2018 published paper
A Dr Cafino in the Philippines worked with FibreTuff customer service for a couple hours to get the appropriate print settings to produce this temporal bone. The printed temporal bone made with FibreTuff filament. After 3D printing a successful temporal bone model for pre surgical planning he drilled into the model at 20,000 RPM for simulation. His goals were achieved and more. This highly sophisticated print, temporal bone was printed in 3 hrs.
FibreTuff is the first bone like 3D printing product with biocompatible ingredients to utilize printed circuits to include but not limited biocompatible bar codes. nScrypt has demonstrated this unique feature which can be applied to CMF for cases where vestibular issues may exist. Strain gages, RF circuits and capacitive touch.
FibreTuff biocompatible filament has been 3D printed in a micropore cellular structure exposed to simulated body fluids without pore closure. Possible opportunities and collaboration for 3D Printing regenerative tissues. Write robert@fibretuff.us for more information.
This 3D printing cranio maxillofacial bone was made with FibreTuff showing a 9 mm thickness. After a paper clip was inserted, simulating a metal staple and removed the image was altered replicating the real life procedure.
FibreTuff President and Founder Robert Joyce has been working on biopolymer technology advancement since 2001 when acquiring an inline compounding sheet extrusion line. Through creative thinking, novel ideas and persistence the company has progressed to help lead in sustainable materials and innovative parts in various industries to include Medical, Cosmetic, Automotive and Furniture.
FibreTuff® Technology is an example of hard work, dedication and belief that the product, compositions and process can make a difference.The company is a leader in Molding, Extruding and 3D Printing polyamide and polyolefin with cellulose fibers. The medical grade composition shows "bone like" qualities to include biocompatibility, bioactivity with radiopacity. There are other functional qualities to include good screw retention, cutting and sawing capability without melting.
FibreTuff has been used by Automotive OEM's, to achieve awards at Society of Plastic Engineers SPE - 2015. In 2021, the Society of Manufacturing Engineers SME awarded a 3D Printing Medical Emerging and Enabling (MEET) to FibreTuff at the RAPID+TCT conference.
Any of the following patents can be licensed from Innovative Plastics and Molding, Inc.
3D Printing "FibreTuff®"
Molded Parts made with "FibreTuff®"
Composition of matter for thermoplastic biopolymer "FibreTuff®"
Composition of matter for thermoplastic biopolymer "FibreTuff®"
USPTO Registered Trademark FibreTuff® S/N 85/955,521
absorbent, non resorbable printed FibreTuff
Mon | 09:00 am – 05:00 pm | |
Tue | 09:00 am – 05:00 pm | |
Wed | 09:00 am – 05:00 pm | |
Thu | 09:00 am – 05:00 pm | |
Fri | 09:00 am – 05:00 pm | |
Sat | Closed | |
Sun | Closed |
This website uses cookies. By continuing to use this site you accept our use of cookies.